Efficacy and Safety of Intra-articular Injections of Hyaluronic Acid Combined With Polydeoxyribonucleotide in the Treatment of Knee Osteoarthritis
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Objective To assess the clinical efficacy and safety of intra-articular injection of hyaluronic acid (HA) combined with polydeoxyribonucleotide (PDRN) in patients with knee osteoarthritis in comparison with that of HA alone.Methods The current single-center, prospective, randomized, double-blind, controlled study was conducted in 36 patients with knee osteoarthritis at our medical institution. All the eligible patients (n=30) were equally assigned to two treatment arms (trial group ‘HA+PDRN’ and control group ‘HA’). For efficacy assessment, the patients were evaluated for the visual analogue scale (VAS) scores, the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the Knee Society Scores (KSS), all of which served as efficacy outcome measures. We monitored time-dependent changes in efficacy outcome measures at baseline and 1, 3 and 6 months. Subsequently, we compared differences in changes in efficacy outcome measures at 6 months from baseline between the two groups. Moreover, we assessed the safety based on the treatment-emergent adverse events (TEAEs), adverse drug reactions (ADRs) and any other complications serving as safety outcome measures.Results There were significant differences in changes in the VAS scores, the WOMAC scores in all domains, except ‘Stiffness’, the total WOMAC scores, and the KSS scores in all the domains at 6 months from baseline between the two groups (p<0.05). In our series, there were no TEAEs, ADRs, and any other complications.Conclusion Intra-articular injections of HA combined with PDRN can also be considered in the treatment of knee osteoarthritis. However, further large-scale and multi-center studies are required to demonstrate the potential of the proposed combination.
Abstract
Objective To assess the clinical efficacy and safety of intra-articular injection of hyaluronic acid (HA) combined with polydeoxyribonucleotide (PDRN) in patients with knee osteoarthritis in comparison with that of HA alone.Methods The current single-center, prospective, randomized, double-blind, controlled study was conducted in 36 patients with knee osteoarthritis at our medical institution. All the eligible patients (n=30) were equally assigned to two treatment arms (trial group ‘HA+PDRN’ and control group ‘HA’). For efficacy assessment, the patients were evaluated for the visual analogue scale (VAS) scores, the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the Knee Society Scores (KSS), all of which served as efficacy outcome measures. We monitored time-dependent changes in efficacy outcome measures at baseline and 1, 3 and 6 months. Subsequently, we compared differences in changes in efficacy outcome measures at 6 months from baseline between the two groups. Moreover, we assessed the safety based on the treatment-emergent adverse events (TEAEs), adverse drug reactions (ADRs) and any other complications serving as safety outcome measures.Results There were significant differences in changes in the VAS scores, the WOMAC scores in all domains, except ‘Stiffness’, the total WOMAC scores, and the KSS scores in all the domains at 6 months from baseline between the two groups (p<0.05). In our series, there were no TEAEs, ADRs, and any other complications.Conclusion Intra-articular injections of HA combined with PDRN can also be considered in the treatment of knee osteoarthritis. However, further large-scale and multi-center studies are required to demonstrate the potential of the proposed combination.
참고문헌 (29)
- Litwic A, "Epidemiology and burden of osteoarthritis", Br Med Bull, 105, pp.185~199 (2013)
- Rosemann T, "Osteoarthritis and functional disability : results of a cross sectional study among primary care patients in Germany", BMC Musculoskelet Disord, 8, pp.79~ (2007)
- Bhatia D, "Current interventions in the management of knee osteoarthritis", J Pharm Bioallied Sci, 5, pp.30~38 (2013)
- Lawrence RC, "Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II", Arthritis Rheum, 58, pp.26~35 (2008)
- Felson DT, "Osteoarthritis: new insights. Part 1. The disease and its risk factors", Ann Intern Med, 133, pp.635~646 (2000)
- Le TK, "Health care costs in US patients with and without a diagnosis of osteoarthritis", J Pain Res, 5, pp.23~30 (2012)
- Iannitti T, "Intra-articular injections for the treatment of osteoarthritis : focus on the clinical use of hyaluronic acid", Drugs R D, 11, pp.13~27 (2011)
- Chard J, "Update : treatment of osteoarthritis", Arthritis Rheum, 47, pp.686~690 (2002)
- Bannuru RR, "Therapeutic trajectory of hyaluronic acid versus corticosteroids in the treatment of knee osteoarthritis : a systematic review and metaanalysis", Arthritis Rheum, 61, pp.1704~1711 (2009)
- Bellamy N, "Viscosupplementation for the treatment of osteoarthritis of the knee", Cochrane Database Syst Rev, (2), pp.CD005321~ (2006)
- Hashizume M, "Desirable effect of combination therapy with high molecular weight hyaluronate and NSAIDs on MMP production", Osteoarthritis Cartilage, 17, pp.1513~1518 (2009)
- Onur TS, "Co-administration of hyaluronic acid with local anaesthetics shows lower cytotoxicity than local anaesthetic treatment alone in bovine articular chondrocytes", Bone Joint Res, 2, pp.270~275 (2013)
- Euppayo T, "Effects of hyaluronic acid combined with anti-inflammatory drugs compared with hyaluronic acid alone, in clinical trials and experiments in osteoarthritis : a systematic review and metaanalysis", BMC Musculoskelet Disord, 18, pp.387~ (2017)
- Zazgyva A, "Polynucleotides versus sodium hyaluronate in the local treatment of knee osteoarthritis", Acta Medica Transilvanica, 2, pp.260~263 (2013)
- Vanelli R, "Efficacy of intra-articular polynucleotides in the treatment of knee osteoarthritis : a randomized, double-blind clinical trial", Knee Surg Sports Traumatol Arthrosc, 18, pp.901~907 (2010)
- Dante Dallari, "Efficacy of Intra-articular Polynucleotides Associated With Hyaluronic Acid Versus Hyaluronic Acid Alone in the Treatment of Knee Osteoarthritis", Clinical Journal of Sport Medicine, pp.1~ (2019), Ovid Technologies (Wolters Kluwer Health)[DOI]
- Kim JK, "Effectiveness of polydeoxyribonucleotide injection versus normal saline injection for treatment of chronic plantar fasciitis : a prospective randomised clinical trial", Int Orthop, 39, pp.1329~1334 (2015)
- Kang KN, "Effect of transforaminal epidural polydeoxyribonucleotide injections on lumbosacral radiculopathy: a case report", Medicine (Baltimore), 96, pp.e7174~ (2017)
- Yoon YC, "Polydeoxyribonucleotide injection in the treatment of chronic supraspinatus tendinopathy : a case-controlled, retrospective, comparative study with 6-month follow-up", Arch Phys Med Rehabil, 98, pp.874~880 (2017)
- Bitto A, "Polydeoxyribonucleotide reduces cytokine production and the severity of collagen-induced arthritis by stimulation of adenosine A(₂A)receptor", Arthritis Rheum, 63, pp.3364~3371 (2011)
- Dougados M, "Response criteria for clinical trials on osteoarthritis of the knee and hip : a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative", Osteoarthritis Cartilage, 8, pp.395~403 (2000)
- 이전경, "Effect of Extracorporeal Shockwave Therapy Versus Intra-articular Injections of Hyaluronic Acid for the Treatment of Knee Osteoarthritis", Annals of Rehabilitation Medicine, 41(5), pp.828~835 (2017), 대한재활의학회
- Haefeli M, "Pain assessment", Eur Spine J, 15(Suppl 1), pp.S17~S24 (2006)
- Bellamy N, "Validation study of WOMAC : a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee", J Rheumatol, 15, pp.1833~1840 (1988)
- Bae SC, "Cross-cultural adaptation and validation of Korean Western Ontario and McMaster Universities(WOMAC)and Lequesne osteoarthritis indices for clinical research", Osteoarthritis Cartilage, 9, pp.746~750 (2001)
- Insall JN, "Rationale of the Knee Society clinical rating system", Clin Orthop Relat Res, (248), pp.13~14 (1989)
- Scuderi GR, "The new Knee Society Knee Scoring System", Clin Orthop Relat Res, 470, pp.3~19 (2012)
- Kim SJ, "Crosscultural adaptation and validation of the Korean version of the New Knee Society Knee Scoring System", Clin Orthop Relat Res, 475, pp.1629~1639 (2017)
- Gennero L, "Protective effects of polydeoxyribonucleotides on cartilage degradation in experimental cultures", Cell Biochem Funct, 31, pp.214~227 (2013)